Clinical Trial Update: Study of the Safety and Efficacy of DPI-386 Nasal Gel on Ocean-Going Vessels [Phase 3]

View source ↗

Summary

Phase 3 study evaluating DPI-386 nasal gel for prevention and treatment of nausea associated with motion sickness; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Motion Sickness

Drugs mentioned

• DPI-386 nasal gel

Snippet

Sponsor: Naval Aeromedical Research Unit, Dayton | Conditions: Prevention of Nausea Associated With Motion Sickness, Treatment of Nausea Associated With Motion Sickness | Phase 3 | Status: UNKNOWN